The “Re-” reasons for pharma LCM: And 6 elements of our ForwardFast branding model

I recently conducted a workshop on strategies affecting pharmaceutical Life Cycle Management strategies. The participants were responsible for next generation products, product enhancements to meet market needs, and new products through the local product release cycle. They work closely with their business development teams and continuously monitor market needs and customer acceptance through sales force […]

Strategic GPS: 6 ways our tool can “map” the impact of licensing on university innovation

As universities and federal labs step up the commercialization of their innovations through tech transfer, the discoveries by faculty members often create “star scientists.” Beyond the impact of star scientists on specific universities or firms, there are many regional benefits. This is just one of the insights on “A Faster Path from Lab to Market” […]

How we’ve applied N-of-8® to uncover new product concepts

Using N-of-8 for new brand concepts can generate high potential new product and service ideas. The “open innovation” approach has long been taken by successful innovators, but it remains difficult – because the “not invented here” syndrome is seductive and stubborn to overcome. Going outside for ideas is much more complex than internally, because so […]

4-part model to create brand CHEMistry with customers

Here’s a summary of the talk I gave to an Asia-Pacific sales and marketing conference in Cebu, Philippines. Life science and technology brands make personal connections with consumers beyond that of many other products. This connection goes beyond mere advertising. Marketers must create brands, experiences, and relationships that embody the intricate balance between the research […]

Bioscience Bridge, LLC 2014